Hereditary Hemorrhagic Telangiectasia (HHT) Center

About this grant

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.  Grant Number: HRSA-26-092. Expected awards: 1.

Eligibility requirements

All of the following criteria must be met:

• Community-based organizations that meet one of the entity types listed as eligible. "Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
• Grant Number: HRSA-26-092

What the funding covers

• Award Maximum: $29,00,000
• Expected Number of Awards: 1
• Total Program Funding: $29,00,000

How to apply

1. 1Applications must be submitted through grants.gov
2. 2Grant Number: HRSA-26-092
3. 3Posted: 2026-03-16

Application tips